Delivery Order SPE2DB25D3306-SPE2DB26FUAPS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,211.16 to AmerisourceBergen Drug Corp for the supply of Primaquine 26.3 mg tablets (100 count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Primaquine is an antimalarial medication commonly used by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) with a contract value of $1,713.32. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Primaquine 26.3 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $4,616.51. The award was made on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Primaquine is an...
- The U.S. Defense Department's Medical Supply Chain has awarded a delivery order valued at $1,362.24 to AmerisourceBergen Drug Corp for the supply of Primaquine 26.3 mg tablets (100-count units). This competitively awarded, firm fixed-price contract was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,788.91 to AmerisourceBergen Drug Corp for 100 tablets of Primaquine 26.3 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Primaquine is an antimalarial medication used primarily for the treatment and prevention of...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.74 to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) on June 16, 2025, with completion scheduled for June 17, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) with a ceiling value of $1,262.78 under a firm fixed-price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,807.27 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) under a firm fixed-price contract. The contract has a ceiling value of $3,419.98 and an ultimate completion date of August 25, 2025. This award is unset-aside and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAPSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count units) on November 4, 2025, with a ceiling value of $2,421.76 and an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Primaquine is an antimalarial medication commonly used by the Department of Defense for malaria prophylaxis and treatment in military personnel and beneficiaries. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains. The company has demonstrated consistent capability to meet federal procurement requirements through competitive awards involving firm fixed-price delivery orders across a wide range of medical products and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/4/25 |